REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

Investigator: Polly Niravath, MD

Study Coordinator: Mary Rose Silvas

Status: Enrolling

ClinicalTrials.gov Number: NCT01984138

Phone: 713.441.1952

Protocol Number: Pro00017710

Description

This study is investigating whether breast cancer patients who experience vaginal dryness while on anti-estrogen treatment could benefit from either vaginal estrogen or from a vaginal moisturizer called Replens.
More to Explore